Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Pediatr Blood Cancer. 2010 Aug;55(2):248–253. doi: 10.1002/pbc.22519

Table IV.

Response to Induction Therapy According to Genotype

g/g t/g t/t g/g vs t/g vs t/t
N % N % N % p-value
Phase 1 (course 1) response
 CR 72 82% 150 85% 135 75% 0.062
 PR 6 7% 6 3% 18 10% 0.045
 Fail 6 7% 12 7% 13 7% 0.984
 Death 4 5% 8 5% 13 7% 0.477
 Unevaluable 3 7 5
Phase 2 (course 2) cumulative response
 CR 58 73% 130 78% 122 70% 0.261
 PR(M1) 4 5% 3 2% 5 3% 0.367
 Fail 8 10% 14 8% 26 15% 0.148
 Death 10 13% 20 12% 21 12% 0.993
 Unevaluable 11 16 10